SlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016Effect of Renal Impairment on Drugs Primarily Eliminated by Metabolism or Biliary Excretion: Review of Data from HCV DAA Drugs and Literature - Dr. Tushar GarimellaView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016Other Viruses: using Wolbachia to interrupt transmission of viral infections such as Dengue, Chikungunya and Zika - Steven Kern, PhDView Slideset
ACAngela ColbersPhDSlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016Timing of the postpartum curve in pharmacokinetic studies in pregnancy should not be too early - Angela Colbers, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016Raltegravir (RAL) Pharmacokinetics (PK) and Safety in HIV-1 Exposed Neonates at High Risk of Infection (IMPAACT P1110) - Dr. Diana ClarkeView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016Pharmacokinetic, Safety and Efficacy of Darunavir/Ritonavir in HIV+ Pregnant Women - Dr. Minh Patrick LeView Slideset
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017Gilead: RSV | Erik MogalianView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017Janssen: Influenza | Thomas Kakuda, PharmDView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017Merck: CMV | Cyrus Badshah, MD, PhDView Video
JRJürgen RockstrohMDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017Con Standpoint | Jürgen Rockstroh, MDView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017Pro Standpoint | Nancy Reau, MDView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017Long Acting Antivirals: Advanced drug delivery | Mark Milad, PharmDView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017DDI’s in Aging HCV infected Patients | Elise Smolders, MScView Video
